University of British Columbia
Placental DNA methylation patterns associated with pathology and maternal age
Abstract
dc:descriptionPlacental pathology is associated with preeclampsia, fetal growth restriction, and adverse fetal heart and brain development. While the link between placental dysfunction and fetal development is compelling, there is a poor understanding of the molecular changes associated with these pathologies. Molecular tools like DNA methylation profiling can be used to explore changes in gene regulation associated with pathology. eoPRED is one DNA methylation-based tool that estimates the similarity of a placental methylome to one of early-onset preeclampsia but may be associated with underlying histopathology. Due to exclusion from previous epigenetic association studies, it is unknown if there are sex chromosome-linked DNA methylation associated with preeclampsia. Additionally, advanced maternal age has been associated with an increase in adverse pregnancy and birth outcomes, which could be due to age-associated placental dysfunction. I thus hypothesized that i) eoPRED would be associated with maternal vascular malperfusion, the underlying pathology of most cases of early-onset preeclampsia; ii) sex-linked differences in DNA methylation would be associated with preeclampsia; and iii) placental DNA methylation would be associated with maternal age. To explore these hypotheses, I used Illumina DNA methylation array data from the Stress Pregnancy and Health dataset (N=493), along with public datasets to evaluate DNA methylation patterns associated with placental pathologies and maternal age. I found that the eoPRED score was associated with maternal vascular malperfusion pathology severity even in the absence of preeclampsia. DNA methylation at only a few sex chromosome sites showed an association with eoPRED score or pathology, but maternal age was not associated with placental DNA methylation. In conclusion, eoPRED score quantifies the severity of placental dysfunction as a continuous variable and could be used to identify associations between placental dysfunction and fetal development. Sex chromosomes should be included in future epigenomic studies, however maternal age does not appear to be a major contributor to placental DNA methylation variation.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Medical Genetics
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Illing, Hannah Johnston
- Contributors dc:contributor
-
- Robinson, Wendy P.
Rights
dc:rights- Statement dc:rights
-
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/91271